slides · global inventory
Solution
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 8,880
Current window 5,671-5,700
Pages 296
Rows per page 30
Slide type
5,671-5,700 of 8,880
28
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
32
The slide shows a heatmap of 43 patient samples across different cancer types, correlating ABS with signature scores.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
41
The slide uses a three-column layout to define the target product profile (TPP) requirements for a drug candidate.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
45
The slide uses a heatmap to display binary synergy results (Yes/No) across three drug combinations, alongside a bar chart showing single-agent sensitivity.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
46
The slide uses a Venn diagram to illustrate the overlap of gene modulation between peripheral blood and primary tumours, and line charts to show dose-response curves for two specific biomarkers.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
47
The slide features a 3D molecular visualization of the protein target.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
48
TPP stands for Target Product Profile.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
50
The slide uses a process-flow layout to describe the company's R&D methodology.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
52
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
53
Includes two scientific diagrams illustrating the mechanism of action and brain penetration.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
54
The slide uses a three-column layout to define technical requirements for a drug candidate.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
57
The slide uses a Pareto front to illustrate the trade-off between CNS score and Potency, highlighting the selection of 'unattractive' compounds.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
59
The slide uses two distinct chart types (dot plot and line chart) to demonstrate the safety profile of a reversible inhibitor.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
64
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
66
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
70
The image shows a protein binding site with color-coded regions (Donor, Apolar, Acceptor) indicating chemical properties.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
72
The chart shows tumor volume over time (D20-D30), with the combination therapy (teal line) showing a flat growth curve compared to monotherapies and vehicle controls.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
10
The slide uses a structured table format to categorize service lines and their specific offerings.First Western Financial | Investor Presentation Deck | 50 slides · First Western Financial
Pitch deck Investor relations Beat · Solution1 hit
03
The slide uses a collage of imagery representing political, legislative, and data-driven contexts to visually reinforce the company's mission.FiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Beat · Solution1 hit
11
FiscalNote | Investor Presentation Deck | 32 slidesFiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
12
The slide uses a process flow diagram to illustrate the technical stack.FiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
14
Uses a tree metaphor for the core technology stack and a grid for the target sectors.FiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
16
The slide uses a PET scan image to demonstrate selective tumor uptake versus normal tissue, and a table to quantify IGF-1R expression across different cancer types.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
20
The slide uses a Y-shaped antibody diagram to illustrate bispecific binding.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
21
The slide highlights a 'vaccine effect' in 13/15 animals and mentions IP protection for these combinations.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
27
The slide uses medical imaging (SPECT/CT) to visually demonstrate the efficacy of a pharmacological strategy.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
32
The slide uses a potency spectrum chart to frame the problem of toxin evolution and a comparison table to highlight the competitive advantages of TATs.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
33
The slide uses a combination of a biological process diagram and a line chart to demonstrate the competitive advantage of the proprietary linker technology.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
17
Gogoro | Investor Presentation Deck | 27 slidesGogoro | Investor Presentation Deck | 27 slides · Gogoro
Pitch deck Investor relations Beat · Smart Battery for Urban SustainabilityLoop · Quick Win Big Bet1 hit
05
The slide uses a hub-and-spoke layout to surround the product image with key value propositions.Hyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit